Form 4/A for DCOY Decoy Therapeutics Inc.
Accepted 2022-11-08 00:00:00 ET · period of report 2022-11-03 · accession 0001615219-22-000144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-11-08 | 2022-11-03 | DCOY | Arthur David J. | CEO, Dir | A - Grant | $1.73 | +10.0K | 21.0K | +91% | +$17.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-03 | A | A | 10,000 | $1.73 | 21,026 | D | — | — |